Prijic Sergej, Buchhorn Reiner
Mother and Child Health Institute of Serbia, R. Dakica St. 6-8; 11070 Belgrade, Serbia, School of Medicine - University of Belgrade, Dr. Subotica St. 8, 11000 Belgrade, Serbia.
Rev Recent Clin Trials. 2014;9(2):58-60. doi: 10.2174/1574887109666140908125402.
Patients with chronic heart failure have prolonged sympathetic stimulation and subsequent worsening of the failing heart function. Beta-blockers (non-selective, cardio-selective, and non-selective with ancillary properties) counteract the effects of prolonged sympathetic stimulation. Beta-blocker therapy results in the improvement of the left ventricular systolic and diastolic function, reversal remodeling, heart rate control, effective prevention of the malignant arrhythmias, and lowering of the both cardiac afterload and preload in patients with chronic heart failure.
慢性心力衰竭患者存在交感神经刺激延长,进而导致心脏功能衰竭恶化。β受体阻滞剂(非选择性、心脏选择性以及具有辅助特性的非选择性)可对抗交感神经刺激延长的影响。β受体阻滞剂治疗可改善慢性心力衰竭患者的左心室收缩和舒张功能、逆转重塑、控制心率、有效预防恶性心律失常,并降低心脏后负荷和前负荷。